Drawing for TAZORAL

USPTO serial 78380307

TAZORAL

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
DEJESUS, YSA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TAZORAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005RECEPTOR-SPECIFIC RETINOIDS FOR DISEASES OF KERATINIZATION AND DISEASES OF THE SKINABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 21, 2005ABN5ABANDONMENT - AFTER PUBLICATION—
Jun 20, 2005EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Mar 22, 2005NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 28, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 8, 2004NPUBNOTICE OF PUBLICATION—
Oct 26, 2004PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 4, 2004ALIEASSIGNED TO LIE—
Sep 22, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 22, 2004DOCKASSIGNED TO EXAMINER—
Mar 24, 2004NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance